Viagra Cure for Erectile Dysfunction

This World AIDS Day New Jersey really has something to celebrate—on November 27, Atlantic City began operation of the first legal syringe exchange program in the state.  The program was made possible because you helped pass the Blood Borne Disease Harm Reduction Act last year.  The Act allowed for the establishment of syringe access programs in six cities.  Atlantic City is the first of those cities to get a program up and running.

But we cannot afford half measures in the fight against HIV/AIDS.  Legislation to allow non-prescription pharmacy sale of syringes is still languishing in the Senate, and time is running out! Take action now.

Last year, this lifesaving legislation passed the Assembly by a wide margin (50-28) but stalled in the Senate Health Committee and never came to the floor of the Senate for a vote. The legislature is now finishing end-of-year unfinished business, so now is the time to pass the bill in the Senate!
 
A2839/S823 would allow for the sale of limited numbers of syringes in pharmacies without prescriptions.  Allowing the sale of limited numbers of syringes in pharmacies is a critical component of a successful HIV/AIDS and hepatitis C prevention program.  New Jersey is one of only three states that require a prescription to purchase a syringe in a pharmacy. 

Please urge Governor Jon Corzine and Senate leaders to work for the passage of S823 during the last days of this legislative session, which ends in January. 

New Jersey has the fifth highest number of adult HIV cases, the third highest number of pediatric HIV cases, and the highest proportion of women infected in the nation.  New Jersey’s rate of infection related to the sharing of contaminated syringes is almost twice the national average.  More than 15,000 New Jerseyans have died from HIV/AIDS contracted from contaminated syringes.  More than 15,000 other New Jerseyans are living with HIV/AIDS caused by the sharing of contaminated syringes. 

Please take a moment to send a fax to legislators urging them to work for passage of this life-saving legislation.  

Thank you for working for meaningful change for this World AIDS Day!

Ethan Nadelmann, executive director of DPA, and Daniel Wolfe, deputy director of the International Harm Reduction Development Project, discuss international drug policy and the impact of Nadelmann's cover article in Foreign Policy magazine.

Ethan Nadelmann, executive director of DPA, and Daniel Wolfe, deputy director of the International Harm Reduction Development Project, discuss international drug policy and the impact of Nadelmann's cover article in Foreign Policy magazine.

Professor of Pharmacology and co-author of Marijuana Myths, Marijuana Facts, John Morgan explains why synthetic marijuana is problemmatic as a substitute for therapies calling for THC, the active ingredient in marijuana.

Professor of Pharmacology and co-author of Marijuana Myths, Marijuana Facts, John Morgan explains why synthetic marijuana is problemmatic as a substitute for therapies calling for THC, the active ingredient in marijuana.